APACT: A phase III trial of nab-Paclitaxel (nab-P) plus Gemcitabine (Gem) vs Gem alone as adjuvant therapy for patients (pts) with resected pancreatic cancer (PC) Meeting Abstract


Authors: Tempero, M. A.; Cardin, D.; Biankin, A.; Goldstein, D.; Moore, M.; O'Reilly, E. M.; Philip, P.; Riess, H.; Macarulla, T.; Yung, L.; Wei, X.; Lu, B.
Abstract Title: APACT: A phase III trial of nab-Paclitaxel (nab-P) plus Gemcitabine (Gem) vs Gem alone as adjuvant therapy for patients (pts) with resected pancreatic cancer (PC)
Meeting Title: 45th Meeting of the American Pancreatic Association and the Japan Pancreas Society
Journal Title: Pancreas
Volume: 43
Issue: 8
Meeting Dates: 2014 Nov 5-8
Meeting Location: Kohala Coast, HI
ISSN: 0885-3177
Publisher: Lippincott Williams & Wilkins  
Date Published: 2014-11-01
Start Page: 1416
Language: English
ACCESSION: WOS:000344362600355
PROVIDER: wos
DOI: 10.1097/MPA.0000000000000231
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly